IP Group (LON:IPO) Shares Pass Above 200-Day Moving Average - Should You Sell?

Key Points

• IP Group's share price recently surpassed its 200-day moving average, currently trading at GBX 52.40 ($0.71).
• Berenberg Bank has lowered its price target for IP Group from GBX 126 to GBX 100, while maintaining a "buy" rating.
• Despite reporting a negative earnings per share (EPS) of GBX (4.55), IP Group has a strong net margin of 106.78% and a current ratio of 9.28.

IP Group Plc (LON:IPO - Get Free Report)'s share price passed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of GBX 49.90 ($0.67) and traded as high as GBX 53.20 ($0.72). IP Group shares last traded at GBX 52.40 ($0.71), with a volume of 2,203,714 shares traded.

Analysts Set New Price Targets

Separately, Berenberg Bank reduced their price objective on shares of IP Group from GBX 126 to GBX 100 and set a "buy" rating for the company in a research note on Wednesday, September 10th. One equities research analyst has rated the stock with a Buy rating, According to data from MarketBeat.com, IP Group has a consensus rating of "Buy" and an average price target of GBX 100.

IP Group Price Performance

The business has a 50 day simple moving average of GBX 56.84 and a two-hundred day simple moving average of GBX 49.90. The firm has a market capitalization of £472.73 million, a P/E ratio of -369.75 and a beta of 1.36. The company has a debt-to-equity ratio of 13.99, a quick ratio of 8.59 and a current ratio of 9.28.

IP Group (LON:IPO - Get Free Report) last issued its quarterly earnings results on Wednesday, September 17th. The company reported GBX (4.55) earnings per share (EPS) for the quarter. IP Group had a net margin of 106.78% and a negative return on equity of 19.85%. On average, sell-side analysts expect that IP Group Plc will post 19.6245031 EPS for the current fiscal year.

About IP Group

IP Group accelerates the impact of science for a better future. As the most active UK based, early-stage science investor, we develop and support some of the world's most exciting businesses in deeptech, life sciences and cleantech (led by Kiko Ventures). Through Parkwalk, the UK's largest growth EIS fund manager, we also back world-changing innovation emerging in leading universities and research institutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.